chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Sharp intermittent pain in upper back on the far right side. Sometimes radiates into the right side of the chest near the nipple.  Lasts for about two to three seconds.  Sometimes it lingers but then it goes away for several minutes.
Getting COVID After the Vaccine; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Getting COVID After the Vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Getting COVID After the Vaccine). At the time of the report, COVID-19 (Getting COVID After the Vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. The treatment information was unknown.
tested positive for COVID; tested positive for COVID; This is a spontaneous report from a contactable consumer (patient's parent). A 24-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection; Batch/Lot number was not reported), via an unspecified route of administration on 19Mar2021, as single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter stated that her daughter, received the first dose of the Pfizer COVID-19 vaccine on 19Mar2021 but then tested positive for COVID, on an unspecified date and was advised not get the second dose until after her symptoms resolved. She was scheduled to get the second dose on 17May2021, caller would like to know if daughter needs to start the series over or could just get the second dose and be done. The caller stated that her daughter received "Depo, a birth control shot that contains hormones" on 05May2021 and was scheduled to get the second dose of the Pfizer COVID-19 vaccine on 17May2021 hence, the caller wanted to know whether there was any information about when she should receive the COVID vaccine after getting the Depo injection. The patient underwent lab test which included COVID test showed positive result, on an unspecified date. The outcome of the events was unknown.   Information about lot/batch number has been requested.
CAD/Acute Chest pain-Possible unstable angina EKG with paced rhythm  -TTE on 09/20/21 with EF 60-65% - telemetry - trend trop x3 negative - aspirin 324mg-- >81mg qD - load with aspirin 324 mg x1 in er done , heparin drip not recommended at this time, npo except medications ED visit to hospital admission within 6 weeks of receiving the COVID vaccine.
Heavy period with lots of cramping, usually no bleeding while on birth control but after the booster, my next period was very heavy (lots of bleeding) and heavy cramping
Bad headache, chiils, extreme fatigue, fever 100.7, small red rash on left arm (not at injection site), slight nausea
patient was administered a 1 mL instead of the 0.5 mL of the second dose; A spontaneous report was received from a physician concerning  64 years old female patient,  who received moderna's COVID-19 vaccine (mRNA-1273) and patient was administered a 1 mL instead of the 0.5 mL of the second dose (Incorrect dose administered).  The patient's medical history, as provided by the reporter was unknown. Concomitant medications as provided by the reporter was unknown  On 18 Feb 2021  prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number:031L20A) in left arm for prophylaxis of COVID-19 infection. The patient experienced mild soreness and fatigue after the first dose.  On 18 Mar 2021, the patient was administered 1 ml instead of 0.5 ml  of the second dose of Moderna vaccine (lot number: 032M20A) intramuscularly in his right arm..     Action taken with mRNA-1273 in response to the event was not applicable.  The outcome of event the patient was administered a 1 mL instead of the 0.5 mL of the second dose was considered resolved.; Reporter's Comments: This report refers to a case of incorrect dose administered for mRNA-1273, lot # 032M20A with no associated AEs.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-049697:Crosslinked with dose 1
10/22/09 Received H1N1 mist, one hour later felt feverish, HA. 10/23/09 nauseated slight fatigue. 10/27/09 sore throat, HA, cough with green sputum sinus pressure. 10/30/09 Given ZITHROMAX 500mg 2 PO x 5 days.
On morning of 2nd day after (April 16) the vaccination (1st dose), I noticed a rash had developed on the inside of both ankles, the top of both feet just above & on the toes, on the fingers (mostly right hand), inside of both wrists, on the underside of both biceps on the arms.  On the morning of the 3rd day after (April 17), noticed the rash was not on the inner thigh as well as on both sides of my torso just below the armpit.  The rash is presenting as small, raised bumps that can be itchy if disturbed.  Some look as if they could be small blisters, but there is no drainage of any kind.
C/O dizziness, malaise, pain, L arm 2 hrs post rec flu shot. BP increased 180/100-155/90 over next several hrs. HR wnl. No hx HPTN or CAD. Eval by PMD at 4:30 that day-placed on HPTN meds. BP remained high in MD office according to client.
Hypoglycaemia; This spontaneous case was reported by a consumer and describes the occurrence of HYPOGLYCAEMIA (Hypoglycaemia) in a 70-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes mellitus insulin-dependent, Addison's disease, Pernicious anemia and Hashimoto's disease.    On 15-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 15-Jan-2021, the patient experienced HYPOGLYCAEMIA (Hypoglycaemia). At the time of the report, HYPOGLYCAEMIA (Hypoglycaemia) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 19-Jan-2021: some of the medical history is added On 02-Feb-2021: No specific follow-up information recorded.; Sender's Comments: Although a temporal association exists, based on the current available information, mechanism of action of mRNA-1237 vaccine and the patient's concurrent condition of autoimmune polyendocrine syndrome, the event hypoglycemia is assessed as unlikely related.
This spontaneous report as received from a Medical Assistant refers to a patient of unknown age and gender. Medical history and concurrent conditions were not provided. On an unknown date, the patient was vaccinated with an improperly stored dose of PROQUAD (Merck) (dose, route, lot number and expiry date were not reported). No adverse effects reported. There was no concomitant medication provided. This is one of several reports received from the same reporter. Additional information has been concomitant.
Anxiety; SOB; Numbness and Tingling to Arms; Pain at Injection Site; Numbness and Tingling to Arms; This is a spontaneous report from a contactable Other HCP.  A 32-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 intramuscular, administered in Arm Left on 13Mar2021 13:00 (Batch/Lot Number: EN6207) age at vaccination of 32-years-old, as single dose, for covid-19 immunisation. Medical history included immune system disorder from an unknown date and unknown if ongoing. The patient was not pregnant and was not pregnant at the time of vaccination. The patient's concomitant medications were not reported. On 13Mar2021 (13:00), the patient experienced anxiety, shortness of breath, numbness and tingling to arms. pain at injection site. The events resulted in Emergency room/department or urgent care. It was unknown if treatments were given. Prior to vaccination, the patient was not diagnosed with COVID-19. Outcome for the events was unknown.  No follow-up attempts are possible. No further information is expected.
Pediatric medical records were received and received concerning an 6 week old male with cleft lip and a history of jaundice, spitting up and blood bilirubin abnormal (WAES # 0708USA01488) who on 29-APR-2008 was vaccinated with ROCOMBIVAX HB.  On 09-APR-2008 a 2 weeks male infant with no with no known allergies was examined.  The weight was 7 pounds 9 ounces, the length 20 3/4 inches, head circumference 14 1/4 inch, temperature 98.4 degrees F, pulse 158, respiratory frequency 40.  The infant was well.  It was noted that the patient spit up when nursing assessment: well child.  On 29-APR-2008 the 4 weeks male infant with no with no known allergies was examined.  The weight was 9 pounds 6 ounces, the length 21 inches, head circumference 14 3/4 inch, temperature 99.2 degrees F, pulse 120, respiratory frequency 32.  The baby was vaccinated with RECOMBIVAX HB IM in left thigh.  The infant was well.  On 19-MAY-2008 plagiocephaly was noted.  On 27-MAY-2008 an 8 weeks male infant with no known allergies was examined.  The weight was 11 pounds 4.5 ounces, the length 22 1/2 inches, head circumference 15 1/2 inch, temperature 99 degrees F, pulse 128, respiratory frequency 30.  Feeding problems reported as "spit up".  The infant was well.  The baby was vaccinated on this same day with:  PREVNAR (C80901) IM in right thigh.  ROTAVIRUS (660596/0211X) PO.  ACTHIB (UF352AA) IM in left thigh.  On 26-JUN-2008 the patient was vaccinated with: TRIPEDIA (C2934AA) IM in left thigh.  IPOL (A0492) SC/IM in right thigh.  On 27-AUG-2008, the patient had an upper respiratory infection.  (WAES # 0809USA02064) No additional information is expected.
Had significant fevers and chills that started the evening of the injection which lasted until 48 hours after.  Lower extremity weakness/ fatigue, started as bilateral symmetric upper gastrocnemius pain two days after injection. This pain improved over the next week and progressed into lower extremity fatigue. This fatigue/ feeling of generalized lower extremity weakness was consistent for the next three weeks. Mild in nature. Did not effect gait. Tired easily. It then progressively worsened over the next week including the feeling of symmetric hamstring fatigue,weakness. Peaking 4 weeks after vaccination. (Lying with legs bent on a couch for more than ten seconds caused fatigue). Ambulating was steady but fatigued easily. Attempting to job was very tiring. It then improved over the next 10 days.  Returned to normal 5-6 weeks after vaccination. No known residual symptoms currently.  Lower extremity only. No upper extremity or respiratory symptoms.
PATIENT EXPERIENCED CRAMPING AND SPOTTING WITH NO PERIOD.  PATIENT EXPEREINCED NO PERIOD IN THE MONTH OF MAY & JUNE, HOWEVER CRAMPING WAS EXPERIENCED BOTH MONTHS. PATIENT EXPERIENCED MENSTRATION IN JULY, EXTREMLY HEAVY. PATIENT DID NOT MENSTRATE IN AUGUST. PATIENT IS A NURSING MOTHER WHOSE LEFT BREAST (SHOT WAS IN THE LEFT ARM) WAS SORE FOR 5 DAYS. NURSING BABY ALSO APPEARED WITH SYMPTOMS OF LETHARGY AND CLAMMY SKIN.
appendicitis; This is a spontaneous report from a contactable consumer (patient). A 22-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose via an unspecified route of administration, administered in left arm on 18Mar2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. There were no medical history and concomitant medications. Patient stated his first dose was 2.5 weeks ago, almost 3 weeks ago and he has his second dose tomorrow (unspecified). Stated he had a bad reaction after first dose. Stated he was "sick for the next day or two" with appendicitis that night on 18Mar2021. Patient stated that he has completely recovered but date was unknown because it was a process. He went to the emergency room and was hospitalized. Therapeutic measures were taken as a result of appendicitis. The event outcome for event was recovered on unspecified date.
Red area of warmth and itching on R thigh on day # 2 after shots.
No rash on injection site. However rash on  both legs and one arm had rash on elbow. The rash became dark purple and very large. I was taking Benedryl, Hydrocortisone and Calamile lotion over the counter with no improvement. I went to the doctors, he prescribed a steroid, the rash lightened however  back pain started, accompanied with stomach aches. Now I have a heaviness on my chest that hurts. It feels like my rib cage or my bones hurt.
I'm having a large amount of pain and stiffness in my neck, on the back, right at the top of the spine; I'm having a large amount of pain and stiffness in my neck, on the back, right at the top of the spine; I'm having a large amount of pain and stiffness in my neck, on the back, right at the top of the spine; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 25Apr2021 at 09:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. On an unknown date in Apr2021, it had been 5 days since the first dose of Pfizer vaccine and the patient was not 100% sure if it was related nor did the patient currently plan to go to a doctor but the patient had large amount of pain and stiffness in the neck, on the back, right at the top of the spine. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events large amount of pain and stiffness in the neck, on the back, right at the top of the spine was unknown at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
11:30 - Pt received Moderna vaccine at Immunization Clinic. 11:35 - Pt in observation area, c/o mild throat swelling, tingling, and dry mouth. She reports hx of allergies to Neosporin and contrast dye. 11:40 - Pt brought to triage area. VSS, BP 117/76 (96), O2 100%, P 77, RR 18. Pt provided orange juice and water. RN Leader  notified and at bedside.  11:50: MD at bedside for evaluation. Pt states symptoms are not worsening. Pt offered PO Benadryl, but declined due to potential for sedative effects and not having a ride home at this time. MD in agreement to hold off on Benadryl - per his instruction, will continue to monitor pt for additional 30 min (1 hr total), and take Benadryl once she arrives home.  12:31 - VSS, BP 116/82 (95), O2 99%, P 75, RR 18, T 97.6. Pt is A&Ox4, speaking in full sentences. Reviewed MD instructions and ER precautions with pt, including to call 911 in case of chest pain, SOB, or throat swelling. Pt verbalizes understanding. Pt is able to ambulate independently to exit of facility.
Chills that last most of the night after the vaccination. Bad head that started in the middle of the night and lasted until mid day the next day. Feel very tired and slept most of next day and still feel weak and tired into the second day. Arm feels weak.
pt recv vax 19NOV97 left clinic & returned to clinic 515PM stated child w/fever exp sz activity in auto & was limp;pt vomited & had fever 101.0 ax;
Patient was given less or half the dose due to a needle malfunction; This case was reported by a pharmacist via call center representative and described the occurrence of accidental underdose in a 76-year-old male patient who received Herpes zoster (Shingrix) (batch number BA5GK, expiry date 4th November 2022) for prophylaxis.   On 4th April 2021, the patient received the 2nd dose of Shingrix (unknown). On 4th April 2021, unknown after receiving Shingrix, the patient experienced accidental underdose. On an unknown date, the outcome of the accidental underdose was unknown.  Additional details were received as follows: The age at vaccination was not reported but could be 75 or 76 years. The reporter stated that the patient was given less or half the dose due to a needle malfunction during the administration of the second dose, which led to accidental underdose. The reporter consented to follow up.
Patient admitted to the hospital with chest pain. Developed viral respiratory infection following vaccine administration that started to improve 3 weeks after vaccination. Then developed chest pain and dyspnea with exertion, deep breathing, sitting up, and laying on his stomach with certain movements. Due to pain, he is unable to maintain previous fitness standards. Patient was admitted to hospital and diagnosed with myopericarditis. He was treated with colchicine and ibuprofen.
Chills; Body aches; swollen lymph node on right side by neck; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), MYALGIA (Body aches) and LYMPHADENOPATHY (swollen lymph node on right side by neck) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040b21a) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to nuts, Fruit allergy, Drug allergy (Omicillin), Allergy to antibiotic (Allergic to Bactrim), Sulfonamide allergy, Drug allergy (Allergy to Keflex), Drug allergy (Morphine), Seasonal allergy, Vegetable allergy (Allergy to Carrots), Vegetable allergy (celery allergy) and Fruit allergy (Allergic to lemon). Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Allergy.    On 12-Aug-2021 at 3:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Sep-2021 at 7:00 PM, the patient experienced CHILLS (Chills), MYALGIA (Body aches) and LYMPHADENOPATHY (swollen lymph node on right side by neck). On 21-Sep-2021, CHILLS (Chills), MYALGIA (Body aches) and LYMPHADENOPATHY (swollen lymph node on right side by neck) had resolved. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No treatment details were reported.   This case was linked to MOD-2021-405344 (Patient Link).
My heart is now having irregular heart beats, is fast beating, & feels like its going to pop out of my chest, in addition to mild chest pressure.  These symptoms all started after I received the first vaccine and were not pre-existing as I'm an extremely healthy, young male. I received the vaccine on 8/20/21 at approximately 7:50pm. The heart racing began around 9:30pm and has not gone away from the date of this submission. It is now 8/27/21 and has been one week since my first shot of Pfizer vaccine. This is a daily occurrence that has resulted in multiple doctors visits and a trip to the emergency room. Further testing is being  pursued to discover why I am now having these symptoms from the vaccine.  I can barely sleep at night as my heart is beating very fast and is not normal for my body.
Whole upper arm was red and rashy which then had extended to the elbow; Itching on arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Whole upper arm was red and rashy which then had extended to the elbow) and PRURITUS (Itching on arm) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).   On 04-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, the patient experienced RASH ERYTHEMATOUS (Whole upper arm was red and rashy which then had extended to the elbow) and PRURITUS (Itching on arm). At the time of the report, RASH ERYTHEMATOUS (Whole upper arm was red and rashy which then had extended to the elbow) and PRURITUS (Itching on arm) outcome was unknown.  Action taken was not applicable.
Pain aggravated; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain aggravated) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.   Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.  No Medical History information was reported.  On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced PAIN (Pain aggravated). At the time of the report, PAIN (Pain aggravated) had not resolved.     No concomitant medication information was reported. No treatment medication information was reported. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
A non-serious spontaneous report of twenty-eight patients received expired FLUMIST was received from a health professional concerning a 12-year-old male. Neither the patient's past medical history nor the concomitant medications were reported. The product expired on 20-Feb-2011. The patient received the expired FLUMIST on 01-Mar-2011. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event was considered resolved.
On May 2, 2022, I noticed my lungs started burning when I was at the gym working out, doing my normal routine of rowing machine, kettle bell swings and box step ups. I could not finish my normal routine. On Wednesday I felt better so I mowed the grass, it took me four hours. I was tired and had a headache and went to bed at 06:30PM ET. On Thursday I woke up with my body achy and a headache would come and go. I took TYLENOL to help ease the pains of both. I tried to go to the gym on Friday but I could not do any part of my routine. I went to the doctor today May 19, 2022, after seven days of taking TYLENOL since I am still achy and the headache still comes and goes. I will get the results of my COVID-19 test later tonight. My doctor has prescribed me Amoxicillin 500mg 2 (1000mg) capsules by mouth three times daily.
itchy swollen conjunctivitis-2 hrs p/vax; migratory urticarial rash beginning 4 hrs p/vax; rash persisted;
patient came in to get a shingrix 2  shot series 9/29/20. unaware that she had recieved 2 shot series in 2018.  records not reviewed as patient claim never had vaccination. she completed 2 shot series 11/26/20.  in total she received 4 shots over 2 and 1/2 years. manufacture could not provide data on 4 vaccinations as there studies were limited to 3 vaccinations. manufacture informed us that any side effects would be similar to original series. (primarily injection site issues) patient made aware of error in receiving additional vaccinations. she has claimed that no adverse effects were noticed with additional vaccination. she will continue to monitor any effects, and follow up with pharmacy.
Felt hot and nervous. Had panic attack and vitals 182/100, 75, 97% RA Given Benadryl 50 mg. Patient denied any HA , chest pain or SOB.  Recheck 168/110, 74, 96% RA Recheck 175/118, 61, 97%RA Recheck 154/85 Patient discharged home.
No adverse medical reaction.  The patient is 14 years old, too young for the Moderna vaccine We have contacted the health department and moderna